AI-generated summary
The authors randomized 101 women receiving chemotherapy for breast cancer to brief combined cognitive behavioral therapy for insomnia with bright light therapy, or to usual treatment with relaxation audio. The authors report greater improvement in insomnia symptoms, fatigue and daytime sleep impairment in the light-combined group at 6 weeks, but no group difference at 3-month follow-up.
- Participants
- 101
- Who or what was studied
- Women receiving intravenous chemotherapy for breast cancer
- Limits stated in the abstract
- The abstract does not report the wavelength of the bright light used, and the benefit was not maintained at 3-month follow-up.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on academic.oup.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Insomnia, Randomized controlled trial, Bright light therapy, Effect size. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.